Wound cleansing apparatus with actives

• US 8,257,327 B2
• Filed: 10/28/2004
• Issued: 09/04/2012
• Est. Priority Date: 10/28/2003
• Status: Active Grant

• Current Assignee: Smith & Nephew PLC
• Original Assignee: Smith & Nephew PLC
• Inventors: Blott, Patrick Lewis, Greener, Bryan, Hartwell, Edward Yerbury, Lee-Webb, Julian, Nicolini, Derek, Martin, Robin Paul, Walker, Tina Michelle, Green, Clare
• Primary Examiner(s): HAND, MELANIE JO
• Application Number:
  US10/576,263
• Publication Number:
  US 20070141128A1
• Time in Patent Office: 2,868 Days
• Field of Search: 604/304, 604/305, 604/307, 604/313, 604/319, 602/41, 424/641, 424/642
• US Class Current: 604/313
• CPC Class Codes: A61M 1/63 with means for emptying the suction container, e.g. by interrupting suction
• CPC Class Codes: A61M 1/915 Constructional details of the pressure distribution manifold
• CPC Class Codes: A61M 1/916 specially adapted for deep wounds
• CPC Class Codes: A61M 1/92 with liquid supply means
• CPC Class Codes: A61M 1/94 with gas supply means
• CPC Class Codes: A61M 1/96 Suction control thereof
• CPC Class Codes: A61M 2205/3344 Measuring or controlling pressure at the body treatment site
• CPC Class Codes: A61M 27/00 Drainage appliance for wounds or the like , i.e. wound drains, implanted drains negative pressure wound therapy devices A61M1/90; implements for holding wound open A61B17/02 ; middle ear drainage A61F11/202
• CPC Class Codes: A61M 3/0216 Pressure
• CPC Class Codes: A61M 3/0229 Devices operating in a closed circuit, i.e. recycling the irrigating fluid
• CPC Class Codes: A61M 35/30 Gas therapy for therapeutic treatment of the skin

Abstract

An apparatus for cleansing and applying therapy or prophylaxis to wounds, in which irrigant fluid containing a physiologically active material from a reservoir connected to a conformable wound dressing and wound exudate from the dressing are recirculated by a device for moving fluid through a flow path which passes through the dressing and a means for fluid cleansing and back to the dressing. The cleansing means (which may be a single-phase, e.g. microfiltration, system or a two-phase, e.g. dialytic system) removes materials deleterious to wound healing, and the cleansed fluid, still containing materials that are beneficial in promoting wound healing, is returned to the wound bed. The dressing and a method of treatment using the apparatus.

Claims

1. An apparatus for aspirating, irrigating and/or cleansing wounds, comprising:

a fluid flow path, comprising;

a conformable wound dressing, comprising a backing layer which is capable of forming a relatively fluid-tight seal or closure over a wound and a wound-facing face, at least one inlet lumen passing through and/or under the wound-facing face and in communication with at least a fluid reservoir, and at least one outlet lumen passing through and/or under the wound-facing face, wherein a relatively fluid-tight seal or closure is formed over the wound at the point at which each inlet lumen and each outlet lumen passes through and/or under the wound-facing face;

a means for fluid cleansing in communication at least with the outlet lumen comprising a two-phase system configured to remove materials deleterious to wound healing from fluid removed from the wound by bringing fluid removed from the wound into direct or indirect contact with a second fluid, wherein fluid removed from the wound and the second fluid are separated by an integer;

a fluid recirculation lumen for directing cleansed fluid from the means for fluid cleansing back into the inlet lumen;

a device for moving fluid through at least the wound dressing and the means for fluid cleansing;

means for supplying physiologically active agents to the wound.

2. An apparatus according to claim 1, wherein physiologically active agents supplied to the wound are selected from the group consisting of autologous, allogeneic and xenogeneic blood or blood products, platelet lysates, plasma or serum, natural purified protein or recombinant-produced protein growth factors, natural purified protein or recombinant produced protein cytokines, materials to achieve the delivery of nucleic acid molecules as active genes, gene-containing vectors, naked molecules, molecules complexed with nucleic acid binding carriers, molecules within liposomes or virus vectors, and a combination thereof.

3. An apparatus according to claim 1, wherein physiologically active agents supplied to the wound are materials that are beneficial in promoting wound healing by removing materials from a wound exudate or by regulating, limiting or inhibiting processes deleterious to wound healing, wherein physiologically active agents are selected from the group consisting of natural purified protein, recombinant-produced protein proteinase inhibitors, inhibitors of inhibitors of angiogenesis, antioxidants, free radical scavengers, degraders, free radical generators and a combination thereof.

4. An apparatus according to claim 1, wherein physiologically active agents supplied to the wound are natural purified protein or recombinant-produced protein debriding agents.

5. An apparatus according to claim 1, wherein physiologically active agents supplied to the wound are selected from the group consisting of nutrients for wound cells, antimicrobials, antifungal agents, antibiotics, antibacterial agents, local analgesics/anaesthetics, and a combination thereof.

6. An apparatus according to claim 1, wherein the integer that separates the fluid removed from the wound and the second fluid is selectively permeable to materials deleterious to wound healing.

7. An apparatus according to claim 1, wherein the integer that separates the fluid removed from the wound and the second fluid is not selectively permeable to materials deleterious to wound healing, and the second fluid comprises or is in contact with a material that removes materials deleterious to wound healing.

8. A method of treating wounds to promote wound healing using the apparatus for aspirating, irrigating and/or cleansing wounds according to claim 1.

9. An apparatus according to claim 1, further comprising means for bleeding the fluid flow path to bleed fluid from the recirculation lumen.

10. A wound treatment apparatus, comprising:

a wound dressing comprising a backing layer configured to form a relatively fluid-tight seal around at least a portion of a wound;

an inlet lumen in fluid communication with the backing layer, the inlet lumen configured to provide a fluid conduit into the backing layer;

an outlet lumen in fluid communication with the backing layer, the outlet lumen configured to provide a fluid conduit out of the backing layer;

a fluid reservoir in fluid communication with the inlet lumen, the fluid reservoir configured to supply an irrigation fluid into the backing layer, wherein the fluid reservoir comprises physiologically active agents and/or an antimicrobial substance;

a pump configured to move fluid through the inlet lumen, the backing layer, and the outlet lumen; and

a spiral shaped member configured to be positioned under the backing layer, the spiral shaped member configured to be positioned in contact with the wound bed when in use.

11. An apparatus according to claim 10, wherein the fluid reservoir comprises a physiologically active component.

12. An apparatus according to claim 11, wherein the physiologically active component is selected from the group consisting of autologous blood product, allogeneic blood product, xenogeneic blood product, platelet derived growth factor, vascular endothelial growth factor (VEGF), transforming growth factor alpha (TGFα

), transforming growth factor beta (TGFβ

-1, 2, or

     3), basic-fibroblast growth factor (b-FGF), epidermal growth factor (EGF), granulocyte-macrophage colony-stimulating factor (GM-CSF), insulin like growth factor-1 (IGF-1), keratinocyte growth factor 2 (KGF2), interleukin 1β

(IL1β

), interleukin 8 (IL-8), tissue inhibitor of metalloproteinases (TIMP 1 to

     4), tissue inhibitor of alpha 1-antitrypsin (AAT), aprotinin, α

-2-macroglogulin, inhibitor of matrix metalloproteinases (MMPs), neutrophil elastase, thrombospondin, kallistatin, ascorbic acid, glutathione, superoxide dismutase (SOD), and hydrogen peroxide.

15. An apparatus according to claim 10, wherein the irrigation fluid comprises an antibacterial derivate of acetic acid.

16. An apparatus according to claim 10, comprising an antimicrobial substance selected from the group consisting of triclosan, iodine, metronidazole, cetrimide, and chlorhexidine acetate.

17. An apparatus according to claim 10, wherein the fluid reservoir comprises an antifungal substance selected from the group consisting of sodium undecylenate, chlorhexidine, iodine, and clotrimoxazole.

23. An apparatus according to claim 10, wherein the spiral member is an inlet manifold configured to be positioned under the backing layer, the inlet manifold having a lumen extending therethrough and a plurality of openings formed along a length of the inlet manifold in fluid communication with the lumen.

24. An apparatus according to claim 23, further comprising a spiral shaped outlet manifold configured to be positioned under the backing layer in use, the outlet manifold having a lumen extending therethrough and a plurality of openings formed along a length of the outlet manifold in fluid communication with the lumen.

13. A wound treatment apparatus, comprising:

a wound dressing comprising a backing layer configured to form a relatively fluid-tight seal around at least a portion of a wound;

an inlet lumen in fluid communication with the backing layer, the inlet lumen configured to provide a fluid conduit into the backing layer;

an outlet lumen in fluid communication with the backing layer, the outlet lumen configured to provide a fluid conduit out of the backing layer;

a fluid reservoir in fluid communication with the inlet lumen, the fluid reservoir configured to supply an irrigation fluid into the backing layer, wherein the fluid reservoir comprises physiologically active agents and/or an antimicrobial substance;

a pump configured to move fluid through the inlet lumen, the backing layer, the outlet lumen;

a fluid cleansing mechanism in fluid communication with the outlet lumen, the fluid cleansing mechanism configured to remove materials deleterious to wound healing from fluid in the outlet lumen; and

a recirculation lumen configured to recirculate fluid from the fluid cleansing mechanism back into the inlet pipe without passing through the fluid reservoir, wherein the fluid recirculation lumen comprises a bleed device configured to bleed fluid from the recirculation lumen to relieve pressure in at least a portion of the apparatus.

14. An apparatus according to claim 13, wherein the fluid cleansing mechanism comprises a two-phase system configured to bring fluid from the outlet lumen into direct or indirect contact with a second fluid, wherein the second fluid comprises a physiologically active component.

18. An apparatus according to claim 14, wherein the second fluid comprises a protease inhibitor, serine protease inhibitor, 4-(2-aminoethyl)-benzene sulphonyl fluoride (AEBSF, PefaBloc), Nα

-p-tosyl-L-lysine chloromethyl ketone (TLCK), ε

-aminocaproyl-p-chlorobenzylamide, cysteine protease inhibitor, matrix metalloprotease inhibitors, carboxyl (acid) protease inhibitor, anti-inflammatory material to bind or destroy lipopolysaccharides, peptidomimetic, anti-oxidant, 3-hydroxytyramine (dopamine), ascorbic acid (vitamin C), vitamin E, glutathione, chelator, ion exchange, desferrioxamine (DFO), 3-hydroxytyramine (dopamine), peptide, cytokine, bacterial cytokine, α

-amino-γ

-butyrolactone, L-homocamosine, and iron III reductant.

19. An apparatus according to claim 13, wherein the fluid reservoir comprises a physiologically active component.

20. An apparatus according to claim 19, wherein the physiologically active component is selected from the group consisting of autologous blood product, allogeneic blood product, xenogeneic blood product, platelet derived growth factor, vascular endothelial growth factor (VEGF), transforming growth factor alpha (TGFα

), transforming growth factor beta (TGFβ

-1, 2, or

     3), basic-fibroblast growth factor (b-FGF), epidermal growth factor (EGF), granulocyte-macrophage colony-stimulating factor (GM-CSF), insulin like growth factor-1 (IGF-1), keratinocyte growth factor 2 (KGF2), interleukin 1β

(IL1β

), interleukin 8 (IL-8), tissue inhibitor of metalloproteinases (TIMP 1 to

     4), tissue inhibitor of alpha 1-antitrypsin (AAT), aprotinin, α

-2-macroglogulin, inhibitor of matrix metalloproteinases (MMPs), neutrophil elastase, thrombospondin, kallistatin, ascorbic acid, glutathione, superoxide dismutase (SOD), and hydrogen peroxide.

21. An apparatus according to claim 13, comprising an antimicrobial substance selected from the group consisting of triclosan, iodine, metronidazole, cetrimide, and chlorhexidine acetate.

22. An apparatus according to claim 13, wherein the fluid reservoir comprises an antifungal substance selected from the group consisting of sodium undecylenate, chlorhexidine, iodine, and clotrimoxazole.